Literature DB >> 2314965

Di George anomaly and velocardiofacial syndrome.

C A Stevens1, J C Carey, A O Shigeoka.   

Abstract

The velocardiofacial syndrome is an autosomal dominant disorder characterized by cleft palate, cardiac anomalies, characteristic facies, and learning disabilities. The Di George anomaly involves developmental defects of the third and fourth pharyngeal pouches, resulting in thymic and parathyroid hypoplasia and cardiac defects. The cases of individuals in two families help substantiate the notion that the Di George anomaly occurs as a feature of the velocardiofacial syndrome. The proband in family 1 was a male infant with persistent hypocalcemia and cardiac defects consisting of truncus arteriosus, atrial septal defect, ventricular septal defect, and abnormal aortic arch vessels. Autopsy revealed absence of thymic and parathyroid tissue, and the Di George anomaly was diagnosed. His father had a submucous cleft palate, T cell dysfunction, and facial features consistent with the velocardiofacial syndrome. This is the third case of male-to-male transmission of velocardiofacial syndrome. The proband of family 2 was a 4-year-old girl with developmental delay, persistent neonatal hypocalcemia, ventricular septal defect, T cell dysfunction, and facial features of the velocardiofacial syndrome. The Di George anomaly has been reported to occur in at least 18 different disorders. The observation that the Di George anomaly is a component manifestation of the velocardiofacial syndrome in these two families provides further evidence that the Di George anomaly is not a distinct syndrome of a single origin but rather a heterogeneous developmental field defect. It is proposed that all previously reported cases of autosomal dominant Di George anomaly are examples of the velocardiofacial syndrome.

Entities:  

Mesh:

Year:  1990        PMID: 2314965

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

1.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11.

Authors:  D A Driscoll; M L Budarf; B S Emanuel
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

2.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.

Authors:  C Carlson; H Sirotkin; R Pandita; R Goldberg; J McKie; R Wadey; S R Patanjali; S M Weissman; K Anyane-Yeboa; D Warburton; P Scambler; R Shprintzen; R Kucherlapati; B E Morrow
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

Review 3.  Velocardiofacial syndrome.

Authors:  A C Pike; M Super
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

4.  Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders.

Authors:  C Carlson; D Papolos; R K Pandita; G L Faedda; S Veit; R Goldberg; R Shprintzen; R Kucherlapati; B Morrow
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  Velocardiofacial syndrome and DiGeorge sequence.

Authors:  R J Shprintzen
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

Review 6.  Phenotype of adults with the 22q11 deletion syndrome: A review.

Authors:  E Cohen; E W Chow; R Weksberg; A S Bassett
Journal:  Am J Med Genet       Date:  1999-10-08

7.  Velocardiofacial syndrome in a mother and daughter: variability of the clinical phenotype.

Authors:  S E Holder; R M Winter; S Kamath; P J Scambler
Journal:  J Med Genet       Date:  1993-10       Impact factor: 6.318

Review 8.  Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognise.

Authors:  A H Lipson; D Yuille; M Angel; P G Thompson; J G Vandervoord; E J Beckenham
Journal:  J Med Genet       Date:  1991-09       Impact factor: 6.318

9.  Juvenile rheumatoid arthritis and del(22q11) syndrome: a non-random association.

Authors:  A Verloes; C Curry; M Jamar; C Herens; P O'Lague; J Marks; P Sarda; P Blanchet
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

10.  Diagnosis of DiGeorge syndrome in nuclei released from archival autoptic heart specimens using fluorescence in situ hybridization.

Authors:  G Calabrese; R Mingarelli; P Francalanci; R Boldrini; G Palka; C Bosman; G Novelli; B Dallapiccola
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.